Diuretic Testing in Chronic Kidney Disease

NARecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2029

Conditions
Kidney Disease, Chronic
Interventions
DIAGNOSTIC_TEST

Diuretic Testing

The administration of hydrochlorothiazide and bumetanide is used to stimulate and assess tubular function.

Trial Locations (1)

3015GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
collaborator

European Research Council

OTHER

lead

Erasmus Medical Center

OTHER